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Abstract

Objective: To evaluate cardiac risk factors and risk scores for prediction of coronary artery
disease (CAD) and adverse outcomes in an emergency department (ED) population judged to be
at low to intermediate risk for acute coronary syndrome (ACS).
Methods: This prospective study was approved by the institutional review board. Written
informed consent was obtained from consecutive ED patients who presented with chest pain and
were evaluated with coronary CTA (cCTA). Cardiac risk factors, clinical presentation, ECG and
laboratory studies were recorded; TIMI and GRACE scores were tabulated. cCTA findings were
rated on a 6 level plaque burden scale and classified for significant CAD (stenosis ≥ 50%).
Adverse cardiovascular outcomes were recorded at 30 days.
Results: Among 250 patients evaluated by cCTA, 143 (57%) had no CAD, 64 (26%)
demonstrated minimal plaque (<30% stenosis), 26 (10%) demonstrated mild plaque (<50%
stenosis), 9 (4%) demonstrated moderate single vessel disease (50-70% stenosis), 2 (1%)
demonstrated moderate multivessel disease and 6 (2%) demonstrated severe disease (>70%

stenosis). Six patients developed adverse cardiovascular outcomes. Among traditional cardiac
risk factors, only age (older) and sex (male) were significant independent predictors of CAD.
Correlation with CAD was poor for TIMI (r=0.12) and GRACE (r=0.09-0.23) scores. cCTA
identified severe CAD in all subjects with adverse outcomes.
Conclusion: Among ED patients who present with chest pain judged to be at low to intermediate
risk of ACS, traditional risk factors are not useful to stratify risk for CAD and adverse outcomes.
cCTA is an excellent predictor of CAD and outcome.

Introduction
The National Ambulatory Medical Care Survey demonstrates an increasing number of
patients presenting annually to the emergency department (ED) with acute chest pain.1 Chest
pain was the principal reason for over 7 million ED visits in 2009.2 As admission of chest pain
patients to a coronary care unit is not cost effective,3 observation units have been created to
improve care and to reduce hospital admissions.4 The current practice of observation and
diagnostic testing of ED chest pain patients results in billions of dollars in annual medical costs.
Initial assessment of the ED patient with chest pain begins with the medical history,
evaluation of cardiac risk factors and assessment of symptoms. The electrocardiogram (ECG),
physical examination and cardiac biomarkers may identify higher risk patients. Risk scoring
systems – including the Thrombolysis in Myocardial Infarction (TIMI)5 and Global Registry of
Acute Coronary Events (GRACE)6 scores – have been validated to confer additional important
prognostic value.7 Triage is often based upon myocardial perfusion imaging8 or other forms of
stress testing.9 A scientific statement of the American Heart Association (AHA) supports
expedited management of low-risk chest pain patients by combining clinical and laboratory
assessments with a confirmatory stress test as “safe, accurate and cost-effective”.10
Conventional standard of care for ED chest pain patients results in a documented miss
rate of 2-5% for acute coronary syndrome (ACS).11,12 Missed ACS and subsequent heart attacks
account for 20-39% of all ED malpractice judgments.13 Several randomized trials have suggested
that coronary CT angiography (cCTA) may be more effective than stress testing for evaluation of
low-risk chest pain in the ED.14,15 Three randomized multicenter trials have recently confirmed
cCTA as a safe and cost-effective diagnostic test to discharge low-risk chest pain patients.16,17,18

These randomized multicenter studies have opened the possibility of widespread cCTA
testing for low risk ED patients presenting with chest pain, though the utility of such testing
depends upon the pre-test probability of disease.19 Many practicing physicians remain convinced
that accurate evaluation of traditional risk factors and clinical presentation can be used for triage
of the low risk ED patient and to limit the number of ED patients who should be referred for
cCTA. The purpose of the current study was to evaluate individual conventional cardiac risk
factors, as well two widely accepted risk scores - TIMI and GRACE - for prediction of coronary
artery disease (CAD) and adverse outcomes in an ED population judged to be at low to
intermediate risk for ACS.

Materials and Methods

This HIPPA compliant clinical protocol was approved by the university institutional
review board. Written informed consent was obtained from each participant prior to enrollment
in the study. The study was conducted over a 36 month period from August 2009 through July
2012 on consecutive patients who presented to the ED with chest pain or similar symptoms that
might represent an anginal equivalent, and who were admitted to the observation unit and
evaluated with coronary CTA (cCTA).
Study Population
The study population included patients presenting to the ED with a chief complaint of
chest pain, shortness of breath, syncope or near syncope, or pain radiating to the neck, shoulder,
back, or arm and not appearing to be musculoskeletal in nature. Each patient underwent
electrocardiography and initial myoglobin and troponin I levels. By agreement with the ED
physicians, cCTA was only obtained on patients who they deemed to be at low to intermediate
risk of ACS after initial clinical and ECG assessment, and who would otherwise be evaluated
with a stress echocardiogram or nuclear perfusion stress test. Patients who were considered high
risk for ACS based upon clinical presentation, ECG changes (with clear ST segment elevation or
depression) or biomarkers (elevated troponins) were admitted to the hospital or sent directly for
cardiac catheterization. Patients with a history of a prior revascularization procedure (bypass
surgery or angioplasty ± stent) were excluded. Patients whose pain was deemed non-cardiac or
whose estimated GFR was below 60ml/min were excluded. The remaining low to intermediate
risk patients were included in the study whenever dedicated cardiac time on the CT scanner was
available within 12 hours of presentation.

History & Laboratory Data Collection
In order to prospectively collect information on study participant risk factors, a coinvestigator who was not involved in performance of the cCTA and who was not involved in the
care of the patient interviewed each patient with a standard structured questionnaire. This
questionnaire was developed in consultation with our cardiologists and ED chest pain division to
provide a complete, succinct description of the presenting complaint and cardiac risk factors that
could be used for statistical analysis. Chest pain was described by location, character (sharp,
aching, burning, tearing, crushing or pressure), radiation (to left arm, jaw/neck, back, right arm,
or other), severity (1-10 scale), number of episodes and duration of pain. Patients were asked if
pain was exacerbated by exertion or emotional stress. Associated symptoms were recorded. Risk
factor evaluation included history of hypertension, hyperlipidemia, diabetes, smoking, prior
myocardial infarct, history of known coronary disease, and family history of coronary disease.
Medications were recorded and patients were specifically asked about aspirin usage in the
previous 7 days. Patient laboratory studies obtained in the ED were reviewed for hyperlipidemia
and elevation of troponins. The 12-lead ECG obtained during ED presentation was reinterpreted
for study purposes by a cardiology co-investigator. The ED physical examination record was
reviewed for body mass index, blood pressure and Killip classification.
Cardiovascular Risk Scores
The TIMI and GRACE risk scores are commonly used for risk assessment among
symptomatic patients with ACS or suspected ACS. For the purpose of this study, an excel
spreadsheet was constructed to compute both the TIMI and GRACE scores of our study patients
based upon their history and risk factors.

The TIMI score consists of seven clinical variables with one point given for each
condition met. The seven parameters include: age 65 years or older, the presence of at least 3 risk
factors for coronary artery disease, a history of prior coronary stenosis greater than or equal to
50%, use of aspirin in the previous 7 days, severe angina defined as experiencing at least 2
episodes of angina within the past 24 hours, ST-segment deviation of at least 0.5mm on ECG,
and the presence of elevated serum cardiac markers. A patient’s TIMI score can easily be
calculated during routine clinical evaluation and often serves as the basis for making future
medical decisions and obtaining additional medical studies. Details of the TIMI scoring system
and a TIMI risk score calculator are available on-line at www.timi.org.
The GRACE score is an alternative risk score to predict outcomes among patients
presenting with ACS. The GRACE model utilizes various parameters including a patient’s age,
Killip class, systolic blood pressure, heart rate, creatinine level, the presence of cardiac arrest on
admission, ECG changes (definition is different than the TIMI criteria; ST-segment deviation
must be at least 1mm), and elevated serum cardiac markers to generate four probabilities: the
probability of death in the hospital and at 6 months from the time of hospital admission, as well
as the probability of death or MI in the hospital and at 6 months from the time of hospital
admission. In contrast to the TIMI scores, the GRACE score is more complicated to compute and
requires use of a calculator. Details of the GRACE scoring system and a GRACE risk score
calculator are available on-line at www.outcomes-umassmed.org/grace.
TIMI and GRACE scores were computed based upon the collected data. For the purpose
of TIMI and GRACE scores, the ECG recorded in the ED at the time of presentation was
reinterpreted by a co-investigator (who is a third year cardiology fellow) using TIMI and
GRACE criteria. As many of our patients complained of atypical chest pain or continuous chest

pain for an extended duration, we contacted the TIMI study group for clarification regarding the
definition of severe anginal symptoms. The presence of continuous chest pain over a long
interval was tabulated as multiple episodes for the purpose of the TIMI score (personal
communication with Dr. Elliott Antman). Four sets of GRACE scores were calculated, including
in-hospital and 6 month scores for death and for death/infarction. These research questionnaires,
as well as the TIMI and GRACE scores, were not viewed by the ED physicians caring for the
patients or by the physician who interpreted the cCTA.
CT Scan Protocol
Imaging was performed with a 256-MDCT scanner (Brilliance iCT, Philips Medical
Systems). Patients with initial heart rates greater than 60 beats/minute were treated with
intravenous metoprolol (5-20 mg) to a target heart rate of 50-60 beats/minute. Sublingual
nitroglycerin spray (800 µg) was administered 2-3 minutes before scanning. Metoprolol was not
given to patients with a history of active asthma within the past 30 days or to those with a history
of recent cocaine use. The dose of metoprolol was limited to 10mg for any patients with a history
of asthma. Blood pressure was monitored continuously during premedication, and no further
premedication was administered when systolic pressure fell below 100mmHg.
A biphasic injection protocol was used with 60 ml of ioversol (Optiray 350, Mallinckrodt
Imaging) followed by 30ml of ioversol mixed with 30ml of 0.9% saline solution, injected at a 56 ml/s. Prospective ECG-triggering with axial imaging was used in patients with a stable cardiac
rhythm and heart rate ≤ 60 beats per minute. Retrospective gating with helical imaging and tube
current modulation was used in the remaining patients. Tube voltage was set to 120 kVp. For
prospective axial scans, tube current was set at 60-100mAs based upon patient size. Estimated
effective biological dose for patients scanned with prospective ECG-triggering was 4mSv,

assuming a 12cm scan length and a normalization factor of 0.017mSv × mGy–1 × cm–1 for the
adult chest.20 For helical scans tube current was generally set at 600 mAs/slice, but was
increased to 800 or 1000mAs/slice for obese patients. Estimated mean biological dose for
patients scanned at 600mAs/slice was 6mSv, assuming a 12cm scan length. Imaging was
initiated by a dynamic bolus monitoring program which was triggered by contrast enhancement
in the left atrium. The CTA was performed during a single breath hold.

CT Image Analysis
Reconstructed images of the coronary arteries were evaluated by two experienced cardiac
radiologists with experience interpreting over 3000 cCTA cases. Disagreements between the two
radiologists were resolved by consensus discussion. Slab maximum intensity projection (MIP)
images were obtained with 5mm slice thickness and rotated in various planes to best visualize
any area of stenosis in all coronary segments. For any patient with evidence of stenosis, a
tracked reconstruction of the coronary arteries was performed to allow evaluation with a curved
multiplanar image and a straightened lumen view (comprehensive cardiac package software;
Philips Brilliance workstation. See Figure 1). Each coronary artery segment was rated as normal,
minimal disease (<30% stenosis), mild disease (<50% stenosis), moderate disease (50-70%
stenosis), or severe disease (>70% stenosis). Based upon these ratings, each cCTA study was
classified on a 6 level plaque burden scale (0 = no plaque, 1 = minimal disease with <30%
stenosis, 2 = mild disease with <50% stenosis, 3 = moderate single vessel disease with 50-70%
stenosis, 4 = moderate multivessel disease, and 5 = severe disease with >70% stenosis).
Outcomes & Clinical Follow-up

For the purpose of this study, a positive cardiac outcome was defined as confirmed ACS
or myocardial infarction, coronary revascularization or cardiac related death within 30 days. A
co-investigator attempted to obtain a telephone follow-up on each patient at 30 days following
the cCTA. If there was no answer or the patient was unavailable, additional follow-up calls were
made in an attempt to reach the patient for up to one year after the cCTA. For those patients who
could not be reached by telephone, hospital medical records were searched for follow-up
information including subsequent admissions to the hospital, cardiac events, or revascularization.
Although the primary endpoint was to identify adverse outcomes at 30 days, in a minority of
patients this follow-up data was obtained from telephone conversations or medical records that
were recorded up to 1 year after the cCTA.

Statistical Analysis
Based upon prior experience with cCTA at our institution, we expected to define
significant CAD with ≥ 50% stenosis in approximately 10% of our low to intermediate risk ED
patients, with adverse outcomes in no more than 2%. As the number of expected adverse
outcomes was very small, the study was powered to identify risk factors that might improve the
prediction of CAD and allow direct triage of these patients without cCTA. Based upon costeffectiveness considerations, further non-invasive testing for CAD is unlikely to be cost effective
when the probability of significant CAD drops below 1% or rises close to 50%.19 Power
calculations were performed assuming a two sample comparison of proportions using a twosided test with an alpha of 0.05. For a risk factor present in 50% of the study population, a
sample size of 250 is calculated to provide 80% power to detect a reduction in CAD rate from

10% to 1%, and 85% power to detect an increase in CAD rate above 25%. For a risk factor that
is present in only 20% of the study population, a sample size of 250 is calculated to provide a
power of 70% to detect an increase in CAD rate above 25%, and 88% power to detect an
increase in CAD rate above 30%.
Statistical analysis was performed by using Stata software (version 12.0, StatCorp). Two
sets of dependent variables were used in the analysis, the presence of coronary disease on cCTA
and the clinical follow-up outcome data. For the purpose of evaluating the predictive value of
risk factors on the presence of coronary disease, significant coronary disease was defined as ≥
50% stenosis in at least one vessel (a score ≥ 3 in our grading system). In order to determine
whether cCTA was predictive of adverse cardiac outcomes, we cross-tabulated the outcome data
with the presence of disease on cCTA.
Univariate analysis: Pearson’s correlation coefficients were computed to evaluate
correlation of TIMI and GRACE scores with the presence of CAD as demonstrated by cCTA. A
chi square test was performed to test the association of binary risk factors (sex, hypertension,
hyperlipidemia, diabetes, smoking, etc) with the presence of coronary disease or an adverse
cardiac outcome. Logistic regression was used to calculate the odds ratio for the association of
binary and continuous risk factors (age, body mass index, severity of pain, TIMI score, GRACE
score) with the presence of significant CAD. When multiple categories of a single risk factor
were present, as is the case for character of chest pain and radiation of chest pain, an odds ratio
was computed for each individual category (ie chest pressure, tightness, etc).
Multivariate analysis: For those risk factors which were found to be significant in the
univariate analysis, multivariate logistic regression was performed to determine which of these

risk factors provided independent significant predictive power for CAD. TIMI and GRACE
scores were included in a further multivariate analysis to determine whether they provided
additional predictive information. A value of p < 0.05 was considered statistically significant for
all statistical analyses.

Results
cCTA studies were obtained on 250 patients evaluated during the study. Demographics of the

study population, tabulation of risk factors and odds ratios for prediction of CAD are reported in
Table 1. Over half the patients sent for cCTA had no visible coronary plaque (n=143; 57% of subjects).
Minimal plaque was present in 64 patients (26%), mild plaque in 26 patients (10%), moderate single
vessel disease was present in 9 patients (4%), moderate multivessel disease was present in 2 patients (1%)
and severe plaque in 6 patients (2%). For the purposes of our analysis, 17 patients were classified as
having significant CAD (stenosis ≥ 50%).
Among traditional risk factors, only age (older), sex (male) and hypercholesterolemia were
significant predictors of CAD in the univariate analysis (Table 1). The mean age of patients with
significant CAD (58.7 years) was significantly greater than the mean age of patients without significant
CAD (50.4 years). Other factors including diabetes, hypertension, hypertension on medication, family
history, smoking history, history of prior infarction, character of chest pain, radiation of chest pain (to the
arm, neck/jaw or back), and severity of chest pain were not significant predictors of CAD. On
multivariate analysis, hypercholesterolemia was correlated with age, but was not a significant independent
predictor of CAD. Age and sex continued to be significant predictors on multivariate analysis. Of note, 5
of the 7 patients who claimed to have a history of prior myocardial infarction demonstrated no evidence
of CAD, and the other 2 had CAD with less than 50% stenosis on cCTA. Although reinterpretation of the
presenting ECG studies by our cardiology co-investigator demonstrated an abnormal result in 17 patients
based upon TIMI criteria and 7 patients based upon GRACE criteria (Table 1), only 1 patient with an
abnormal ECG result demonstrated significant CAD.
Table 2 tabulates the association of TIMI scores, which varied from 0-5, with the presence of
significant CAD on cCTA. Of note, 15/16 patients with coronary stenosis ≥ 50% had a TIMI score < 2,
while 30/31 patients with a TIMI score ≥ 3 had no significant coronary stenosis. Table 3 presents the

Pearson correlation coefficients between risk scores (TIMI and GRACE) and the cCTA grade of CAD,
demonstrating only a weak correlation between risk score and plaque burden. Although TIMI and
GRACE scores were significantly correlated with each other, the r-values for the correlation of TIMI with
the various GRACE scores were in the range of 0.24-0.31 (p<0.001).
The data in tables 1, 2 and 3 demonstrate that many patients in our study with significant
coronary disease on cCTA are missed by traditional risk factor and/or risk score assessment. Furthermore,
a majority of patients with the more elevated TIMI and GRACE scores in this study were, in fact, free of
coronary disease. Logistic regression of TIMI scores for prediction of significant CAD with stenosis ≥
50% failed to demonstrate a significant association. Logistic regression of GRACE scores for prediction
of CAD with stenosis ≥ 50% did demonstrate a significant association, but the odds ratio was in the range
of 1.01-1.03, suggesting weak predictive ability. Furthermore, when any of the GRACE scores was
combined with patient age and sex in a multivariate logistic analysis, the GRACE score did not provide
additional predictive power for significant CAD (odds ratios = 0.98-0.99; p≥0.4).
Follow-up clinical data were obtained in 221/250 patients, demonstrating 6 adverse
cardiovascular events within 30 days. The 6 events included 2 patients with confirmed ACS, 2 patients
with myocardial infarction, and 2 patients who required revascularization (1 with coronary bypass surgery
and 1 with a stent). All 6 adverse cardiovascular events occurred in patients with severe CAD identified
by cCTA (cCTA grade = 5). Although 5/6 patients with adverse events were either hypertensive or
diabetic and 2/6 did complain of exacerbation of chest pain with exertion, all 6 adverse cardiovascular
events occurred in patients with a TIMI score < 2 (Table 4). Among the 31 patients with TIMI scores ≥ 3,
none experienced an adverse cardiovascular event on 30 day follow-up. Although all patients who
experienced adverse cardiovascular events did have at least one cardiac risk factor, these risk factors were
commonly found among patients who did not suffer adverse events, and were not sufficiently specific to
triage patients for discharge versus further observation/evaluation.

Discussion

Our study confirms the ability of cCTA to predict which patients are at risk for adverse
cardiovascular events, as all patients who had an adverse event by 30 days demonstrated the
presence of severe CAD on cCTA. Our data also support the conclusion that it is safe to
discharge a patient with a normal cCTA or a cCTA showing less than 50% stenosis, as no
adverse outcomes were documented in the 233 patients with less than 50% coronary stenosis.
Furthermore, among conventional criteria used to risk stratify coronary disease, only increasing
age and male sex were independent predictors of significant CAD. This finding is concordant
with the landmark publication on the probability of CAD by Diamond and Forrester which
defined the pre-test likelihood of disease based upon age, sex and presentation of symptoms.21
Finally, our data suggest that other commonly employed risk factors are poor predictors for the
presence of CAD in ED patients, and should not be used to triage low to intermediate risk
patients away from cCTA. These findings are concordant with those of the ROMICAT trial
subanalyses that demonstrate only “modest” discriminatory capacity of the Goldman, Sanchis
and TIMI risk scores for the diagnosis of ACS, as compared with “good” discriminatory capacity
for plaque burden on cCTA.22,23

Why were the remaining traditional risk factors for CAD and risk scores for adverse
outcomes not useful in this low to intermediate risk chest pain population? Numerous studies
have validated the application of TIMI and GRACE risk scores to predict patient outcome in the
setting of ACS.24 For patients presenting to the ED with potential ACS, TIMI and GRACE are
the most commonly used scores for risk stratification, with receiver operating characteristic
curve (ROC) areas of 0.757 and 0.728 respectively for the prediction of 30-day event rates.25 A
comparison of TIMI, GRACE and PURSUIT scores concluded that all three risk scores

demonstrated “good predictive accuracy for death or myocardial infarction at 1 year, and enabled
the identification of high-risk subsets of patients who will benefit most from myocardial
revascularization performed during initial hospital stay.”26

So why did these risk scores fare poorly in our study of patients who presented to the ED
with potential ACS? Firstly, we should note that the ROC areas of 0.757 and 0.728 cited above
do not suggest excellent predictive value. Furthermore, the comparison of TIMI, GRACE and
PURSUIT cited above with “good predictive accuracy” reports ROC areas of 0.551-0.585 for
TIMI and 0.672-0.715 for GRACE.

An additional explanation for the poor performance of TIMI and GRACE scores in our
study is likely related to the patient population. For patients with confirmed ACS, TIMI and
GRACE scores have been validated to predict outcome and distinguish patients who may benefit
most from therapy, but no risk score has been validated for identification of ACS in the ED
setting.27 The low to intermediate risk ED chest pain population is very different from the
clinical trial and registry settings of ACS patients in which the TIMI and GRACE scores were
developed. Furthermore, although three vessel and left main disease are more common in ACS
patients with TIMI scores of 3-4 as compared to patients with TIMI scores of 0-2, significantly
more single vessel disease may be present in ACS patients with TIMI scores of 0-2 as compared
with those of scores 5-7.28 It is likely that the ACS patients who are most commonly seen in the
ED are those with single vessel disease and lower risk scores rather than those with extensive
CAD and higher risk scores. Our data underscore the importance of risk model validation in an
appropriate target population rather than a clinical trial population to establish its generalizability
before integration into clinical practice.29

So how can we best expedite management of the low to intermediate risk patient who
presents to the ED with chest pain? Patients who present with chest pain that can be attributed to
a non-cardiac cause should require no further cardiac testing. Patients who appear to be at high
risk for ACS based upon typical anginal symptoms, ECG findings and biomarkers should be
referred for cardiac catheterization. However, the remaining large group of low to intermediate
risk patients with atypical chest pain cannot be easily stratified by risk factors and scores. As
noted in the introduction, randomized trials have demonstrated excellent negative predictive
value for cCTA in evaluation of patients presenting to the ED with chest pain, and have
suggested that cCTA may be more cost-effective than traditional stress testing for rapid
discharge of these ED chest pain patients.14-18 Another significant advantage of cCTA over stress
testing is the ability to assess simultaneously for non-cardiac etiologies of chest pain in the
mediastinum, lungs and chest wall. In appropriate clinical situations where both cardiac and noncardiac vascular causes of chest pain are suspected, a “triple rule-out” CTA study can evaluate
the aorta, coronary arteries and pulmonary arteries and expedite discharge of up to 75% of
patients presenting to the ED with atypical chest pain.30,31

A recent editorial in the New England Journal of Medicine critiqued the use of cCTA for
low risk ED patients citing the “Choosing Wisely” campaign for diagnostic testing, and declared:
“The underlying assumption … is that some diagnostic test must be performed before
discharging these low-to-intermediate-risk patients from the emergency department. This
assumption is unproven and probably unwarranted”.32 This editorial appears to oppose the
recommendations of the 2010 AHA scientific statement that supports expedited management of
low-risk ED chest pain patients by combining clinical assessment with a confirmatory diagnostic
test to exclude ischemia as “safe, accurate and cost-effective”.10 Our study suggests that it would

be unwise to discharge low to intermediate risk ED patients on the basis of risk factors and
scores without confirmatory testing, as cCTA did identify a small percentage of patients with
significant CAD (17/250 = 6.8%) and 30 day adverse events (6/221 = 2.7%) who might not
otherwise be detected based upon clinical presentation to the ED. It is also unlikely that our ED
physicians would be willing to discharge low to intermediate risk patients when missed
CAD/ACS and subsequent heart attacks account for 20-39% of all ED malpractice judgments.13
A recent analysis by the Physician Insurers Association of America states “Between 1985 and
2012, the third most common patient condition for which claims were filed against emergency
physicians were Acute Myocardial Infarctions (AMIs) . . . Claims involving AMIs resulted with
an indemnity payment 52% of the time with an average payment of $261,856".33

Several limitations of our study design should be noted. The accuracy of risk factor
assessment depends upon accurate recording of risk factors, and patients are often uncertain of
their own history or unable to adequately explain their symptoms. This uncertainty is illustrated
by the 7 patients who claimed to have had a prior myocardial infarction, but who had no
significant coronary disease on cCTA. Furthermore, clinical history and risk factor assessment is
often quite variable in the ED setting. For the current study, we attempted to address this issue by
prospectively interviewing all patients with a standardized history and risk factor questionnaire
that included all standard risk factors as well as all data needed to compute TIMI and GRACE
risk scores. This questionnaire was based upon an existing chest pain assessment form which
was modified after discussions with our cardiologists and ED observation unit physicians, and
expanded to incorporate additional information required for TIMI and GRACE scores. When
there was uncertainty regarding a risk factor, we checked back with the medical records and ED
chart. With respect to the follow-up data, we initially wanted to collect all follow-up data at 30

days. However, because we were unable to contact many patients within this time interval, the
telephone follow-up period was expanded to increase the follow-up rate, and additional followup was obtained from medical records. Nonetheless, 30 day follow-up data could not be obtained
for 29 patients, representing 11.6% of the patients involved in the study. Furthermore, although
30 day follow-up data should be sufficient to demonstrate the safety of ED discharge, this short
term follow-up is not sufficient to demonstrate the long-term prognostic utility of cCTA. Finally,
as the focus of this study was upon CAD and cardiovascular outcomes, the 30 day follow-up was
focused upon cardiac events but we did not tabulate the non-cardiac pathology detected by
cCTA, nor did we obtain follow-up for non-cardiac adverse events.
The low rate of adverse outcomes among ED patients is a limitation for statistical
analysis of the risk factors, and might interfere with detection of statistically significant risk
factors. Considering those variables with odds ratios > 1.5 in table 1, it is possible that a larger
study population would have found statistical significance in the risk factors of hypertension,
diabetes, a description of tearing chest pain, and exacerbation of chest pain with exertion.
Nonetheless, our outcome results demonstrate that these risk factors did not have good
discriminating ability for the limited number of adverse cardiovascular outcomes in our study
population. In order to improve our statistical power to demonstrate significant risk factors, we
chose to analyze the predictive value of traditional cardiac risk factors and risk scores for both
CAD and clinical outcomes. Some degree of CAD was present in 43% of the study population,
and significant CAD with greater than 50% stenosis was present in 7% of the study population.
Since the development of ACS requires the presence of underlying coronary disease, CAD is
reasonable as a proxy marker for potential future development of an adverse cardiovascular
event.

Despite these limitations, our data demonstrate that among patients who present to the
ED with chest pain and are assessed to be at low to intermediate risk of ACS, traditional risk
factors, TIMI and GRACE scores do not predict plaque burden on cCTA or adverse
cardiovascular outcomes. cCTA is an effective strategy to triage these patients, but risk factors
cannot be used to decide which patients should have cCTA in the low to intermediate risk group
seen in our ED. Specifically, cCTA identified patients with significant CAD who would be
missed by evaluation of risk factors, TIMI and GRACE scores. cCTA expedited the discharge of
over 75% of patients – even those with higher risk scores - based upon normal or minimal
disease in the coronary arteries. In conclusion, for a patient who presents to the ED with chest
pain and is assessed to be at low to intermediate risk of ACS, cCTA is an appropriate diagnostic
study and is superior to clinical assessment by risk factors and risk scores for patient triage.

Figure caption:

Figure 1. Coronary artery grading system for stenosis, demonstrating curved multiplanar and straightened
lumen views of the left anterior descending artery (LAD) in 6 patients.
A. Normal LAD
B. Minimal disease (arrow) with <30% stenosis.
C. Mild disease (arrow) with <50% stenosis.
D. Moderate disease (arrow) with 50-70% stenosis.
E. Severe disease (arrow) with >70% stenosis. Follow-up: treated with stent, symptoms resolved.
F. Severe disease (arrow) with >70% stenosis, and more proximal disease with moderate 50-70% stenosis
(arrowhead). Follow-up: Sent to cath lab for recurrent symptoms, and diagnosed with ACS.
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B. Minimal disease (arrow) with <30% stenosis.

Figure 1. Coronary artery grading system for stenosis, demonstrating curved multiplanar and straightened
lumen views of the left anterior descending artery (LAD) in 6 patients.
C. Mild disease (arrow) with <50% stenosis.

Figure 1. Coronary artery grading system for stenosis, demonstrating curved multiplanar and straightened
lumen views of the left anterior descending artery (LAD) in 6 patients.
D. Moderate disease (arrow) with 50-70% stenosis.

Figure 1. Coronary artery grading system for stenosis, demonstrating curved multiplanar and straightened
lumen views of the left anterior descending artery (LAD) in 6 patients.
E. Severe disease (arrow) with >70% stenosis. Follow-up: treated with stent, symptoms resolved.

Figure 1. Coronary artery grading system for stenosis, demonstrating curved multiplanar and straightened
lumen views of the left anterior descending artery (LAD) in 6 patients.
F. Severe disease (arrow) with >70% stenosis, and more proximal disease with moderate 50-70% stenosis
(arrowhead). Follow-up: Sent to cath lab for recurrent symptoms, and diagnosed with ACS.
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